[90,91] The National Kidney Foundation recommends fenofibrate dosing should be reduced by 50% in patients with a GFR between 60 and 90 ml/min/1.73 m 2 and the dosage reduction should be 75% in ...

Renal impairment (CrCl<50mL/min): initially 54mg/day. Discontinue if inadequate response after 2 months on max dose. Avoid statins. Potentiates oral anticoagulants (monitor). Allow at least 1 hour ...

Fenofibrate 67mg, 134mg ... Discontinue if inadequate response after 2 months on max dose. Avoid statins. Potentiates oral anticoagulants (monitor). Allow at least 1 hour before or 4–6 hours ...

Neither clinical trial is testing fenofibrate at a therapeutic dose – that will come if results from the initial window trials are promising, Dr. O'Neill says. Much is still unknown. However ...